您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Enpp/Carbonic anhydrase-IN-1
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Enpp/Carbonic anhydrase-IN-1
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Enpp/Carbonic anhydrase-IN-1图片
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
Enpp/Carbonic anhydrase-IN-1 (compound 1e) 是一种有效的Enppcarbonic anhydrase抑制剂,对 NPP1、NPP2、NPP3、CA-II、CA-IX 的IC50值分别 1.36、1.35、3.00、0.88、1.02 μM。Enpp/Carbonic anhydrase-IN-1 对癌细胞具有抗增殖活性,对正常细胞具有低细胞毒性。Enpp/Carbonic anhydrase-IN-1 诱导细胞凋亡 (< a href="apoptosis" target="_blank">apoptosis)。
生物活性

Enpp/Carbonic anhydrase-IN-1 (compound 1e) is a potentEnppandcarbonic anhydraseinhibitor withIC50s of 1.36, 1.35, 3.00, 0.88, 1.02 μM for NPP1, NPP2, NPP3, CA-II, CA-IX respectively. Enpp/Carbonic anhydrase-IN-1 shows antiproliferative activity forcancercells and low cytotoxic against normal cells. Enpp/Carbonic anhydrase-IN-1 induces (< a href="apoptosis" target="_blank">apoptosis)[1].

IC50& Target[1]

CA Ⅱ

0.88 μM (IC50)

CA Ⅸ

1.02 μM (IC50)

NPP1

1.36 μM (IC50)

NPP2

1.35 μM (IC50)

NPP3

3.00 μM (IC50)

体外研究
(In Vitro)

Enpp/Carbonic anhydrase-IN-1 (compound 1e) (0-100 μM; ) 抑制癌细胞生长,对 K-562、RPMI-8226、SR、COLO 205、HT-29、SF-539 细胞的 IC50值分别为 0.32、0.40、0.58、0.87、0.40、0.96 μM[1].
Enpp/Carbonic anhydrase-IN-1 (0-2 μM) 对正常乳腺上皮细胞 (HME1) 和正常皮肤成纤维细胞 (F180) 显示低细胞毒性,IC50值均大于 50 μM[1].
Enpp/Carbonic anhydrase-IN-1 (0.32, 0.64 μM) 以剂量依赖的方式诱导 K-562 细胞凋亡[1]

Cell Proliferation Assay[1]

Cell Line:K-562, RPMI-8226, SR, COLO 205, HT-29, SF-539 cells
Concentration:0-100 μM
Incubation Time:
Result:Inhibited the cell growth with IC50s of 0.32, 0.40, 0.58, 0.87, 0.40, 0.96 μM for K-562, RPMI-8226, SR, COLO 205, HT-29, SF-539 cells, respectively.

Apoptosis Analysis[1]

Cell Line:K-562 cells
Concentration:0.32, 0.64 μM
Incubation Time:
Result:Induced apoptosis in a dose-dependent manner.
分子量

411.51

Formula

C23H25NO4S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.